Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human...

Area of Science:

• Biotechnology
• Immunology
• Assay Development

Background:

• Biomarkers like cytokines are crucial for disease diagnosis, prognosis, and treatment response prediction.
• Protein microarray technology allows simultaneous quantification of multiple inflammatory mediators.
• High costs of commercial protein microarray systems limit accessibility.

Purpose of the Study:

• To develop and validate an affordable in-house protein microarray platform.
• To enable simultaneous quantitative analysis of multiple protein biomarkers.
• To assess the platform's accuracy, precision, and comparability with established methods.

Main Methods:

• Development of a bespoke protein microarray system.
• Validation of the microarray platform according to FDA guidelines for pharmacokinetic assays.
• Comparison of cytokine detection with the "gold standard" ELISA format.

Main Results:

• The in-house microarray system demonstrated accuracy and precision within FDA limits for most cytokines.
• No significant differences were observed between the microarray and ELISA for cytokine detection.
• The system showed potential for expansion to detect a wider range of biomarkers.

Conclusions:

• A custom-built protein microarray platform provides accurate, precise, and reproducible multiplexed biomarker quantification.
• The developed system is comparable to commercial ELISA but offers greater customization and cost-effectiveness.
• This platform facilitates advanced biomarker analysis in various disease settings.